Meet Our Team

Social entrepreneur in the fields of patient-oriented health care and inclusive education. He studied pharmacy, was state-registered as a pharmacist and earned a PhD in Pharmacology.

Philipp worked 20 years in pharma industry and worked closely with patients for a variety of purposes. He is a passionate advocate of patient engagement.

Robert is a patient advocate that has worked across four different EU countries. He is skilled at uniting international rare disease patient groups to address common goals.

Ulrike is a doctor’s assistant with over 8 years of experience in the fields of cardiology, general and internal medicine and surgery. She graduated with honors in health care management.

Christian provides a very solid understanding and experience regarding the german pricing and reimbursement system to the team, including the importance of patient relevance data

Marina Rempel studied psychology with a focus on quantitative and qualitative research methodology.
She has practical experience in ...

Serielle shows expertise in market, health economics and reimbursement analysis and medical device digital marketing

Sheila Khawaja, Patient Expert at admedicum, is based in Trieste, Italy. 

Many years of advocacy and patient engagement experience with industry, healthcare systems, healthcare professionals, patient organisations, academic institutions and charities.

Frank has 48 years experience as a patient with a rare and deadly genetic disease called “Alpha1 Antrypsin Deficiency”.

Nancy Meyerson-Hess has over 30 years of experience in clinical research. She has led global teams of clinical research professionals within pharmaceutical and ...

Rainer Herzog is a Senior healthcare industry executive with an excellent track record in leading international organizations.

Rachel has over a decades worth of experience of the Global Pharmaceutical Industry with diverse roles in R and D, Commercial teams and Patient Affairs ...

Maryze is a rare disease advocate and expert by experience regarding drug development, active patient involvement, empowerment related issues and building networks.